Brief: Acadia Pharmaceuticals Q1 EPS USD 0.02
06/05/2026 21:05
May 06 (Reuters) - Acadia Pharmaceuticals Q1 product sales USD 268.062 million. Q1 operating expenses USD 272.678 million Q1 pretax profit USD 3.981 million Q1 net income USD 3.637 million
Recent news on Acadia Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
U.S. STOCKS ON THE MOVE-Fortrea, Nuvation Bio, Acadia Pharmaceuticals
Acadia Pharma jumps after EU panel reverses opinion on neurological disorder drug
Brief: Daybu® (Trofinetide) Recommended For Approval In The European Union By CHMP